연구동향 분석

천식 약물유전체 연구에서 시스템 생물학 접근

박흥우 ( Heung Woo Park ) 2014년

논문상세정보
인용/피인용
' 천식 약물유전체 연구에서 시스템 생물학 접근' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • asthma
  • pharmacogenetics
  • systems biology
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,455 0

0.0%

' 천식 약물유전체 연구에서 시스템 생물학 접근' 의 참고문헌

  • eQTL analysis in humans
    Franke L Methods Mol Biol 573 : 311 ~ 328 [2009]
  • Using Bayesian networks to analyze expression data
    Friedman N J Comput Biol 7 : 601 ~ 620 [2000]
  • Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
    Israel E Lancet 364 : 1505 ~ 1512 [2004]
  • The use of single-nucleotide polymorphism maps in pharmacogenomics
    McCarthy JJ Nat Biotechnol 18 : 505 ~ 508 [2000]
  • The ubiquitous nature of epistasis in determining susceptibility to common human diseases
    Moore JH Hum Hered 56 : 73 ~ 82 [2003]
  • The pharmacogenetics research network: from SNP discovery to clinical drug response
    Giacomini KM Clin Pharmacol Ther 81 : 328 ~ 345 [2007]
  • The meaning of systems biology
    Kirschner MW Cell 121 : 503 ~ 504 [2005]
  • Terminology-driven mining of biomedical literature
    Nenadic G Bioinformatics 19 : 938 ~ 943 [2003]
  • TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids
    Tantisira KG Proc Natl Acad Sci U S A 101 : 18099 ~ 18104 [2004]
  • Systems biology: its practice and challenges
    Aderem A Cell 121 : 511 ~ 513 [2005]
  • Systems biology in pharmacogenomic research: the way to personalized prescribing?
    Koster ES Pharmacogenomics 10 : 971 ~ 981 [2009]
  • Significant variability in response to inhaled corticosteroids for persistent asthma
    Szefler SJ J Allergy Clin Immunol 109 : 410 ~ 418 [2002]
  • STUDENTJAMA. The challenges of whole-genome approaches to common diseases
    Moore JH JAMA 291 : 1642 ~ 1643 [2004]
  • Probability, statistics, and computational science
    Beerenwinkel N Methods Mol Biol 855 : 77 ~ 110 [2012]
  • Primer on medical genomics. Part XIV: Introduction to systems biology: a new approach to understanding disease and treatment
    Morel NM Mayo Clin Proc 79 : 651 ~ 658 [2004]
  • Predicting response to short-acting bronchodilator medication using Bayesian networks
    Himes BE Pharmacogenomics 10 : 1393 ~ 1412 [2009]
  • Pharmacogenomics: translating functional genomics into rational therapeutics
    Evans WE Science 286 : 487 ~ 491 [1999]
  • Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysis
    Qiu W Hum Mol Genet 23 : 5017 ~ 5024 [2014]
  • Pharmacogenomics : drug disposition, drug targets, and side effects
    Evans WE N Engl J Med 348 : 538 ~ 549 [2003]
  • Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?
    Davies SM Hematology Am Soc Hematol Educ Program : 111 ~ 117 [2006]
  • Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast
    Klotsman M Pharmacogenet Genomics 17 : 189 ~ 196 [2007]
  • Pharmacogenetics of response to statins: where do we stand?
    Maitland-van der Zee AH Curr Atheroscler Rep 7 : 204 ~ 208 [2005]
  • Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
    Drazen JM Nat Genet 22 : 168 ~ 170 [1999]
  • Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group
    Malmstrom K Ann Intern Med 130 : 487 ~ 495 [1999]
  • Moving towards individualized medicine with pharmacogenomics
    Evans WE Nature 429 : 464 ~ 468 [2004]
  • Lebrikizumab treatment in adults with asthma
    Corren J N Engl J Med 365 : 1088 ~ 1098 [2011]
  • Integrative systems biology approaches in asthma pharmacogenomics
    Dahlin A Pharmacogenomics 13 : 1387 ~ 1404 [2012]
  • Inhibition of mutated, activated BRAF in metastatic melanoma
    Flaherty KT N Engl J Med 363 : 809 ~ 819 [2010]
  • Heterogeneity of therapeutic responses in asthma
    Drazen JM Br Med Bull 56 : 1054 ~ 1070 [2000]
  • Guidance for industry: E15 definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories
  • Global analysis of the impact of environmental perturbation on cis-regulation of gene expression
    Grundberg E PLoS Genet 7 : e1001279 ~ [2011]
  • Genomics and natural language processing
    Yandell MD Nat Rev Genet 3 : 601 ~ 610 [2002]
  • Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma
    Tantisira KG N Engl J Med 365 : 1173 ~ 1183 [2011]
  • Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus
    Tantisira KG Am J Respir Crit Care Med 185 : 1286 ~ 1291 [2012]
  • Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene
    Himes BE PLoS Genet 8 : e1002824 ~ [2012]
  • Genetics, statistics and human disease: analytical retooling for complexity
    Thornton-Wells TA Trends Genet 20 : 640 ~ 647 [2004]
  • Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids
    Park HW J Allergy Clin Immunol 133 : 664-9.e5 ~ [2014]
  • FDA approves updated warfarin (coumadin) prescribing information: new genetic information may help providers improve initial dosing estimates of the anticoagulant for individual patients
  • Extracting meaning from functional genomics experiments
    Quackenbush J Toxicol Appl Pharmacol 207 (2 Suppl) : 195 ~ 199 [2005]
  • Dynamic relationships between the genome and exposures to environments as causes of common human diseases
    Sing CF World Rev Nutr Diet 93 : 77 ~ 91 [2004]
  • Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids
    Tantisira KG Hum Mol Genet 13 : 1353 ~ 1359 [2004]
  • Combinatorial pharmacogenetics
    Wilke RA Nat Rev Drug Discov 4 : 911 ~ 918 [2005]
  • Characterization of within-subject responses to fluticasone and montelukast in childhood asthma
    Szefler SJ J Allergy Clin Immunol 115 : 233 ~ 242 [2005]
  • Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan
    Chen P N Engl J Med 364 : 1126 ~ 1133 [2011]
  • Bioinformatics approaches for detecting gene-gene and gene-environment interactions in studies of human disease
    Ritchie MD Neurosurg Focus 19 : E2 ~ [2005]
  • An application of bioinformatics and text mining to the discovery of novel genes related to bone biology
    Gajendran VK Bone 40 : 1378 ~ 1388 [2007]
  • ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts
    Litonjua AA Am J Respir Crit Care Med 178 : 688 ~ 694 [2008]
  • A primer on learning in Bayesian networks for computational biology
    Needham CJ PLoS Comput Biol 3 : e129 ~ [2007]
  • A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics
    Duan QL Pharmacogenomics J 13 : 130 ~ 136 [2013]
  • A genome-wide association study of bronchodilator response in Latinos implicates rare variants
    Drake KA J Allergy Clin Immunol 133 : 370 ~ 378 [2014]